<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06330000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P63096</UniProt_ID>
  <Seq_Length>354</Seq_Length>
  <Molecule_Weight>40361</Molecule_Weight>
  <KEGG_ID>hsa:2770</KEGG_ID>
  <Orthology_ID>K04630</Orthology_ID>
  <EBI_ID>EBI-618639</EBI_ID>
  <Function_Summary>Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division.</Function_Summary>
  <Pfam_ID>PF00503:G-alpha</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Adenylate cyclase-inhibiting G alpha protein</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.</Detail>
      <Keyword>Signal transducer activity</Keyword>
      <Ontology_ID>GO:0004871</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a complex of G-protein beta/gamma subunits.</Detail>
      <Keyword>G-protein beta/gamma-subunit complex binding</Keyword>
      <Ontology_ID>GO:0031683</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a metabotropic serotonin receptor.</Detail>
      <Keyword>Metabotropic serotonin receptor binding</Keyword>
      <Ontology_ID>GO:0031821</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with GTP, guanosine triphosphate.</Detail>
      <Keyword>GTP binding</Keyword>
      <Ontology_ID>GO:0005525</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.</Detail>
      <Keyword>Synaptic transmission</Keyword>
      <Ontology_ID>GO:0007268</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process resulting in the physical partitioning and separation of a cell into daughter cells.</Detail>
      <Keyword>Cell division</Keyword>
      <Ontology_ID>GO:0051301</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.</Detail>
      <Keyword>Cell cycle</Keyword>
      <Ontology_ID>GO:0007049</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP.</Detail>
      <Keyword>Inhibition of adenylate cyclase activity by G-protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007193</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>178</Position>
      <PTM_Type>ADP-ribosylarginine</PTM_Type>
    </PTM>
    <PTM>
      <Position>351</Position>
      <PTM_Type>ADP-ribosylcysteine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF</Protein_Seq>
    <DNA_Seq>GAAATCAGTGCACCTTTTGTGGGGCCTCTGAGATGGGGCTGAAGCGTCTTTCCTGTTAACTTCCTATGGCGACTCCTTAAGTGGTCAAGGAGCGCTGATTACATTCCCCCTGCGCTGAGAAAAGGCTGCGCTGGATGCTTGATTTTTCTTGCTGTGGGGGCATGGAAGCCACCCAAGTGGGGTTGGGAAGCTTTGCTTTAGTAGTAGGCAAGGCAGATACTCGAGTGGTGAAAACTGCTGTGAAAGAGCGAGAGGGTCACGCCAGACAACAGGGTTCTGTCTCCGCTGCCACCGTTTCTGATGAATGAGATTTGCCAGGTGCTGGTGAATCTGGTAAAAGTACAATTGTGAAGCAGATGAAAATTATCCATGAAGCTGGTTATTCAGAAGAGGAGTGTAAACAATACAAAGCAGTGGTCTACAGTAACACCATCCAGTCAATTATTGCTATCATTAGGGCTATGGGGAGGTTGAAGATAGACTTTGGTGACTCAGCCCGGGCGGATGATGCACGCCAACTCTTTGTGCTAGCTGGAGCTGCTGAAGAAGGCTTTATGACTGCAGAACTTGCTGGAGTTATAAAGAGATTGTGGAAAGATAGTGGTGTACAAGCCTGTTTCAACAGATCCCGAGAGTACCAGCTTAATGATTCTGCAGCATACTATTTGAATGACTTGGACAGAATAGCTCAACCAAATTACATCCCGACTCAACAAGATGTTCTCAGAACTAGAGTGAAAACTACAGGAATTGTTGAAACCCATTTTACTTTCAAAGATCTTCATTTTAAAATGTTTGATGTGGGAGGTCAGAGATCTGAGCGGAAGAAGTGGATTCATTGCTTCGAAGGAGTGACGGCGATCATCTTCTGTGTAGCACTGAGTGACTACGACCTGGTTCTAGCTGAAGATGAAGAAATGAACCGAATGCATGAAAGCATGAAATTGTTTGACAGCATATGTAACAACAAGTGGTTTACAGATACATCCATTATACTTTTTCTAAACAAGAAGGATCTCTTTGAAGAAAAAATCAAAAAGAGCCCTCTCACTATATGCTATCCAGAATATGCAGGATCAAACACATATGAAGAGGCAGCTGCATATATTCAATGTCAGTTTGAAGACCTCAATAAAAGAAAGGACACAAAGGAAATATACACCCACTTCACATGTGCCACAGATACTAAGAATGTGCAGTTTGTTTTTGATGCTGTAACAGATGTCATCATAAAAAATAATCTAAAAGATTGTGGTCTCTTTTAAGTTTTGCAGTTCATGGTAAAATGCATTTTCAAACCAAATGAGTACTTATATATGGATCTCTGTAGACTAGAGTCTTGCAGCAACACAGAATGTAATATAAGGCAAATGCATCTGGGACTTGACCAAAGTTGTTCTGTTTTGTTTTTTTAACTGAAAGTAACAGAAGGACCTTTCTTAAATGTGACAGATGGTCCTGCAGTGTGAAACTGAAGGACAGTGTTAAAGCTGGGCTCTAGTATATTGATGATTTCTGCATAAGTGTAAATATGCAAATGTATGTATACATGTATTTATGACTTTAGTTTTCGACATTATTTTTAGGTTTTAAGAGTGGCAACTTAGGATTTTAGGGTGATGGCTTTGGAAATAACATAAATATACCTTGTACTGAATGACAGACTATTACTACGTTTGCCAGTTTTAAACAGCTTTATTTATGTTCATGTCCTGTAAATTTTTAAGTACAGTAATTAATATTAGGAAACATTACAGCCCTTATCTAGATTATATGTATACTTGTATTAATAAAAATGTTATTTGTACAAACATTGCACAGACTATTTTAATAACATGATTTGTTCTTTAAATTTTATGTGTTTTATTGAAATGTTCTTAAGATGAATACACCTGCCTTTGGATCAACTATTTAAACATTGTATGCATTTTGATTTTTCCTACTTTAAGAAAATAAAATAATTTAATTTTACATTAGATTCCACGTTAGATTTGGTTTGAAAAACTAAAATTTCAGATTTCTGAGGATATACTGTCTTAGACTTATTGTACACACTTAGTTTTTATTCACTTGTTTTCACTCTGAATTTTAATATTTGGCTGATATGAATGCATTGCCTCAAAGGTGATGTCATCTTAATTTTTATTCACTTTAAATAACTACATTTTTGTTTATAACTAAGTTTGGAGGGATCCTAAGAGCATTTTTGTGGGTAAAAAAAAAACCTGTGGACATAATGAATTTTGAGACATTGATTGGTGAGGCTTTTATTTCCCTTGAGGAGTCTCTTGTACCTAGCATACATGATAGCTCCTTGTTGGGAAGATAACAAGAAGGATCTTTGAATACTCTATTGCTGATATAATGCAAGATTTAAATTTATACATATAACTAATTTCAAATGTAATTATCACACTATGTTAAAATTACTTTTTTCCCTTAGATAATTCAAATTTCTCCACTTGCTTGAGATTATATCATTTCTTTTTCAATTATACTATTATTTCTGAGAATGAAATGGACGATTACACTTAGAAAATGAGTAATAGTGTTTAATAAGTCAGTGATTATATGTGTGCTCAAATAAGTGTTATGTATCAGCTAGATACTGAGCTTTGATAGAATAATTTTCTTTTGATTATTCATGATGTGTCATCTCTGACCTTGTTTCAGCAAAGTAAACAGCACTCCCCACCCCACCCTCCTTTTTTTACTCATCTTGGAAAAGGTTAGTCTTTCAGTACACGTTGCTGGTAAGTAGTTTCCAAGTTACGTGTTGTCACTGGGTTGAAGTATATTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTAACCATAAACTATATTCATATCTGTTTCATTTGGAGGATTTTCTTCTTTGTAATGTAAAGAAATTCAAAGTTATCAAAGTTCCTTAAATGTGTTAGTTTAGATTCTTTATGTGCCTTTCATGAAAGATATGTTTTCATTAATTTTACTGGTGGACCTGTAATATCCACATTGTGAAGCTGTGTATGAAATTCAACTATAATATGAATAAATTTGAATCATGAGAATTATGGGTTAAAAAGCCACAAAGAAGCACATATTGGTGACCATCATTAATGAAATCCTGAACTTTATTCTGTGTAATTGTGTTAATAAATCCTAATAAATTTAAATTTTTAAAATTTTACAAAC</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Midbody</CellLocal>
      <Ontology_ID>GO:0030496</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
      <Ontology_ID>GO:0005856</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Heterotrimeric G-protein complex</CellLocal>
      <Ontology_ID>GO:0005834</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Centrosome</CellLocal>
      <Ontology_ID>GO:0005813</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>GNAI1</Gene_Name>
    <Gene_ID>2770</Gene_ID>
    <Genbank_ACCN>NM_001256414</Genbank_ACCN>
    <Protein_ACCN>NP_001243343</Protein_ACCN>
    <HGNC_ID>4384</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2770</Gene_URL>
    <UCSC_ID>uc003uhb.1</UCSC_ID>
    <EMBL_ID>ENSG00000127955</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P81274</Uniprot_ID>
      <Gene_Name>GPSM2</Gene_Name>
      <EBI_ID>EBI-618655</EBI_ID>
      <PPI_EBI_URL>EBI-618639,EBI-618655</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q14980</Uniprot_ID>
      <Gene_Name>NUMA1</Gene_Name>
      <EBI_ID>EBI-521611</EBI_ID>
      <PPI_EBI_URL>EBI-618639,EBI-521611</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Pertussis</Disease_Name>
      <Disease_Detail>Pertussis</Disease_Detail>
      <Disease_DB>PRT037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pertussis?search=GNAI1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Mechanism underlying the critical contribution of a switch II residue in a heterotrimeric G-protein alpha subunit during C. elegans asymmetric cell division</PDB_Title>
      <PDB_ID>2EBC</PDB_ID>
      <Resolution>2.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EBC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural determinants underlying the temperature-sensitive nature of a Galpha mutant in asymmetric cell division of Caenorhabditis elegans</PubMed_Title>
      <Author>Johnston, C.A., et al.</Author>
      <Journal>J.Biol.Chem.(2008)283:21550-21558</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18519563?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of activated G-alpha-i1 bound to a nucleotide-state-selective peptide: Minimal determinants for recognizing the active form of a G protein alpha subunit</PDB_Title>
      <PDB_ID>2G83</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2G83</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Minimal Determinants for Binding Activated Galpha from the Structure of a Galpha(i1)-Peptide Dimer.</PubMed_Title>
      <Author>Johnston, C.A., et al.</Author>
      <Journal>Biochemistry(2006)45:11390-11400</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16981699?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human G[alpha]i1 Bound to the GoLoco Motif of RGS14</PDB_Title>
      <PDB_ID>1KJY</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KJY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural determinants for GoLoco-induced inhibition of nucleotide release by Galpha subunits.</PubMed_Title>
      <Author>Kimple, R.J., et al.</Author>
      <Journal>Nature(2002)416:878-881</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11976690?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A Galpha-i1 P-loop mutation prevents transition to the activated state</PDB_Title>
      <PDB_ID>3QE0</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QE0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A P-loop Mutation in Galpha Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis</PubMed_Title>
      <Author>Bosch, D.E., et al.</Author>
      <Journal>Plos Pathog.(2012)8:e1002553-e1002553</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22383884?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the G202A mutant of human G-alpha-i1</PDB_Title>
      <PDB_ID>3UMS</PDB_ID>
      <Resolution>2.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UMS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Correction for Regulators of G-protein Signaling accelerate GPCR signaling kinetics and govern sensitivity solely by accelerating GTPase activity</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the heterodimeric complex of human RGS16 and activated Gi alpha 1</PDB_Title>
      <PDB_ID>2IK8</PDB_ID>
      <Resolution>2.71</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IK8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.</PubMed_Title>
      <Author>Soundararajan, M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:6457-6462</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18434541?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the AMF-bound conformation of a G-alpha-i1 mutant with enhanced GTPase activity</PDB_Title>
      <PDB_ID>2PZ3</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
    <PDB>
      <PDB_Title>Structure of G-Alpha-I1 bound to a GDP-selective peptide provides insight into guanine nucleotide exchange</PDB_Title>
      <PDB_ID>1Y3A</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y3A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of G-Alpha-I1 bound to a GDP-selective peptide provides insight into guanine nucleotide exchange</PubMed_Title>
      <Author>Johnston, C.A., et al.</Author>
      <Journal>Structure(2005)7:1069-1080</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16004878?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of a G-alpha-i1 mutant with enhanced affinity for the RGS14 GoLoco motif.</PDB_Title>
      <PDB_ID>3ONW</PDB_ID>
      <Resolution>2.38</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ONW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Determinants of Affinity Enhancement between GoLoco Motifs and G-Protein {alpha} Subunit Mutants.</PubMed_Title>
      <Author>Bosch, D.E., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:3351-3358</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21115486?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN G ALPHA I1 BOUND TO A DESIGNED HELICAL PEPTIDE DERIVED FROM THE GOLOCO MOTIF OF RGS14</PDB_Title>
      <PDB_ID>2XNS</PDB_ID>
      <Resolution>3.41</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XNS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Computational Design of the Sequence and Structure of a Protein-Binding Peptide.</PubMed_Title>
      <Author>Sammond, D.W., et al.</Author>
      <Journal>J.Am.Chem.Soc.(2011)133:4190</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21388199?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A Galpha P-loop mutation prevents transition to the activated state: G42R bound to RGS14 GoLoco</PDB_Title>
      <PDB_ID>3QI2</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QI2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A P-loop Mutation in Galpha Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis</PubMed_Title>
      <Author>Bosch, D.E., et al.</Author>
      <Journal>Plos Pathog.(2012)8:e1002553-e1002553</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22383884?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure Of Human G[alpha]i1 Bound To The Goloco Motif Of Rgs14</PDB_Title>
      <PDB_ID>2OM2</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2OM2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based Protocol for Identifying Mutations that Enhance Protein-Protein Binding Affinities.</PubMed_Title>
      <Author>Sammond, D.W., et al.</Author>
      <Journal>J.Mol.Biol.(2007)371:1392-1404</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17603074?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>RETRACTION: A Structural Basis for Nucleotide Exchange on G-alpha-i Subunits and Receptor Coupling Specificity</PDB_Title>
      <PDB_ID>2HLB</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the heterodimeric complex of human RGS1 and activated Gi alpha 1</PDB_Title>
      <PDB_ID>2GTP</PDB_ID>
      <Resolution>2.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GTP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.</PubMed_Title>
      <Author>Soundararajan, M., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:6457-6462</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18434541?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05145</Pathway_ID>
      <Pathway_Title>Toxoplasmosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04727</Pathway_ID>
      <Pathway_Title>GABAergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04713</Pathway_ID>
      <Pathway_Title>Circadian entrainment</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04540</Pathway_ID>
      <Pathway_Title>Gap junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04728</Pathway_ID>
      <Pathway_Title>Dopaminergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04915</Pathway_ID>
      <Pathway_Title>Estrogen signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05012</Pathway_ID>
      <Pathway_Title>Parkinson's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04022</Pathway_ID>
      <Pathway_Title>cGMP-PKG signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04713</Pathway_ID>
      <Pathway_Title>Circadian entrainment</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05142</Pathway_ID>
      <Pathway_Title>Chagas disease (American trypanosomiasis)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04727</Pathway_ID>
      <Pathway_Title>GABAergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04725</Pathway_ID>
      <Pathway_Title>Cholinergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04723</Pathway_ID>
      <Pathway_Title>Retrograde endocannabinoid signaling</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05133</Pathway_ID>
      <Pathway_Title>Pertussis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04725</Pathway_ID>
      <Pathway_Title>Cholinergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05145</Pathway_ID>
      <Pathway_Title>Toxoplasmosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04540</Pathway_ID>
      <Pathway_Title>Gap junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04062</Pathway_ID>
      <Pathway_Title>Chemokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04022</Pathway_ID>
      <Pathway_Title>cGMP-PKG signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04261</Pathway_ID>
      <Pathway_Title>Adrenergic signaling in cardiomyocytes</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04724</Pathway_ID>
      <Pathway_Title>Glutamatergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04726</Pathway_ID>
      <Pathway_Title>Serotonergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04914</Pathway_ID>
      <Pathway_Title>Progesterone-mediated oocyte maturation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04971</Pathway_ID>
      <Pathway_Title>Gastric acid secretion</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Digestive system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04360</Pathway_ID>
      <Pathway_Title>Axon guidance</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04723</Pathway_ID>
      <Pathway_Title>Retrograde endocannabinoid signaling</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04360</Pathway_ID>
      <Pathway_Title>Axon guidance</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04724</Pathway_ID>
      <Pathway_Title>Glutamatergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04730</Pathway_ID>
      <Pathway_Title>Long-term depression</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04915</Pathway_ID>
      <Pathway_Title>Estrogen signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04713</Pathway_ID>
      <Pathway_Title>Circadian entrainment</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Environmental adaptation</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04611</Pathway_ID>
      <Pathway_Title>Platelet activation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05030</Pathway_ID>
      <Pathway_Title>Cocaine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04024</Pathway_ID>
      <Pathway_Title>cAMP signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04916</Pathway_ID>
      <Pathway_Title>Melanogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04670</Pathway_ID>
      <Pathway_Title>Leukocyte transendothelial migration</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05032</Pathway_ID>
      <Pathway_Title>Morphine addiction</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fb.b.bb.ee.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1y3a</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00860009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>